Guggenheim Trims Relay Therapeutics (NASDAQ:RLAY) Target Price to $28.00
newscatcher
2023-03-12 10:33
Guggenheim Trims Relay Therapeutics (NASDAQ:RLAY) Target Price to $28.00
Relay Therapeutics ( NASDAQ:RLAY – Get Rating ) had its target price cut by Guggenheim from $45.00 to $28.00 in a report published on Thursday morning, The Fly reports. Several other research analysts also recently commented on RLAY. Oppenheimer assumed coverage on Relay Therapeutics in a research note on Thursday, February 2nd. They set an outperform rating and a $33.00 target price for the company. HC Wainwright boosted their price target on Relay Therapeutics from $43.00 to $46.00 and gave the company a buy rating in a research note on Tuesday, March 7th.

https://www.dailypolitical.com/2023/03/12/guggenheim-trims-relay-therapeutics-nasdaqrlay-target-price-to-28-00.html

#dailypolitical
Göm kommentarerna Kommentarer (0)

Du måste logga in före du kommenterar